BioMarin Pharmaceutical (BMRN) Q2 2020 Earnings Report
MX:BMRN Q2 2020 EPS Results
- Actual EPS
- -MXN 3.02
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -MXN 3.97
MX:BMRN Q2 2020 Revenue Results
- Actual Revenue
- MXN 7.95B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +9.84%
Earnings Announcement Details
- Quarter
- Q2 2020
- Date
- 08/04/2020
- Time
- After Close
- Conference Call
- Tuesday, August 4, 2020
Q2 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:BMRN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 02, 2026 | 2026 (Q3) | -1.57- | -3.02 | ― | |
| Aug 06, 2026 | 2026 (Q2) | 17.8822.66 | 23.23 | -2.44% (-0.57) | |
| May 04, 2026 | 2026 (Q1) | 13.0714.35 | 17.94 | -20.00% (-3.59) | |
| Feb 23, 2026 | 2025 (Q4) | 3.19-4.53 | 12.08 | -137.50% (-16.62) | |
| Oct 27, 2025 | 2025 (Q3) | -5.29-3.02 | 10.39 | -129.09% (-13.41) | |
| Aug 04, 2025 | 2025 (Q2) | 16.2623.23 | 10.39 | 123.64% (+12.84) | |
| May 01, 2025 | 2025 (Q1) | 13.4817.94 | 8.69 | 106.52% (+9.25) | |
| Feb 19, 2025 | 2024 (Q4) | 10.0812.08 | 2.08 | 481.82% (+10.01) | |
| Oct 29, 2024 | 2024 (Q3) | 10.0310.39 | 3.97 | 161.90% (+6.42) | |
| Aug 05, 2024 | 2024 (Q2) | 6.7610.39 | 5.48 | 89.66% (+4.91) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed